Division of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital, White Building, Rm 270, 55 Fruit Street, Boston, MA, 02114, USA.
Abdom Radiol (NY). 2016 Apr;41(4):677-705. doi: 10.1007/s00261-016-0665-3.
Percutaneous image-guided ablation is now commonly performed in many institutions for the treatment of hepatocellular carcinoma, liver metastases, and renal cell carcinoma in select patients. Accurate interpretation of post-ablation imaging is of supreme importance because treatment algorithms for these diseases rely heavily on imaging to guide management decisions. The purpose of this pictorial essay is to provide abdominal imagers with a review of the indications for percutaneous ablation in the abdomen, a basic overview of ablation modalities in clinical use today, the expected post-ablation imaging findings in the liver and kidney, and potential complications of hepatic and renal ablation procedures.
经皮影像引导消融术现在在许多机构中常用于治疗肝癌、肝转移瘤和特定患者的肾细胞癌。准确解读消融术后的影像学表现至关重要，因为这些疾病的治疗方案严重依赖影像学来指导管理决策。本文旨在为腹部影像学医生提供腹部经皮消融术的适应证概述，介绍目前临床应用的消融方式的基本知识，肝脏和肾脏消融术后的预期影像学表现，以及肝、肾消融术的潜在并发症。
